AEON
Price:
$0.668
Market Cap:
$7.90M
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Industry
Biotechnology
IPO Date
2023-07-24
Stock Exchange
AMEX
Ticker
AEON
According to AEON Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 223.66%. This represents a change of 341.53% compared to the average of 50.66% of the last 4 quarters.
The mean historical ROE of AEON Biopharma, Inc. over the last ten years is -3.45%. The current 223.66% ROE has changed -6574.83% with respect to the historical average. Over the past ten years (40 quarters), AEON's ROE was at its highest in in the September 2023 quarter at 267.27%. The ROE was at its lowest in in the June 2024 quarter at -587.23%.
Average
-3.45%
Median
18.28%
Minimum
-257.51%
Maximum
251.32%
Discovering the peaks and valleys of AEON Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.27%
Maximum Annual ROE = 251.32%
Minimum Annual Increase = -158.50%
Minimum Annual ROE = -257.51%
| Year | ROE | Change |
|---|---|---|
| 2025 | 71.28% | -148.48% |
| 2024 | -147.03% | -158.50% |
| 2023 | 251.32% | 1.27% |
| 2022 | 18.28% | -22.81% |
| 2021 | 23.68% | 49.85% |
| 2020 | 15.80% | -106.14% |
The current ROE of AEON Biopharma, Inc. (AEON) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
58.52%
5-year avg
43.51%
10-year avg
-3.45%
AEON Biopharma, Inc.’s ROE is greater than Cingulate Inc. (-365.16%), greater than Cellectar Biosciences, Inc. (-264.79%), greater than Bolt Biotherapeutics, Inc. (-100.90%), greater than Marker Therapeutics, Inc. (-73.29%), greater than OSR Holdings, Inc. (-15.90%), less than Clene Inc. (233.93%), less than Abpro Corporation (73.51%), greater than Mustang Bio, Inc. (-35.38%), greater than Aptorum Group Limited (-5.90%), less than Lyra Therapeutics, Inc. (1.21%),
| Company | ROE | Market cap |
|---|---|---|
| -365.16% | $27.97M | |
| -264.79% | $8.91M | |
| -100.90% | $7.67M | |
| -73.29% | $14.36M | |
| -15.90% | $9.63M | |
| 233.93% | $61.95M | |
| 73.51% | $1.06M | |
| -35.38% | $4.93M | |
| -5.90% | $5.28M | |
| 1.21% | $781.13K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AEON Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AEON Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AEON Biopharma, Inc.'s ROE?
How is the ROE calculated for AEON Biopharma, Inc. (AEON)?
What is the highest ROE for AEON Biopharma, Inc. (AEON)?
What is the 3-year average ROE for AEON Biopharma, Inc. (AEON)?
What is the 5-year average ROE for AEON Biopharma, Inc. (AEON)?
How does the current ROE for AEON Biopharma, Inc. (AEON) compare to its historical average?